You can find details general procedures of publishing at the Clinical Research Bureau's website. In addition, the senior research staff in each department will be able to provide specific details on publishing procedures in their own fields of research.
If you are writing an article but your chosen journal does not supply a suitable output style for citing references, take a look at the output styles at the library website.
Open Access to the research results means that this material is digital, online, free of charge, and free of most copyright and licensing restrictions. See the the University Library site for further details of Open Access.
On the website of the Equator Network you can find publication standards for reporting on many different types of study's. The Equator Network is directed by an international Steering Group that brings together leading experts in health research methodology, statistics, reporting and editorial work. The network is an ‘umbrella’ organisation that brings together researchers, medical journal editors, peer reviewers, developers of reporting guidelines, research funding bodies and other collaborators with mutual interest in improving the quality of research publications and of research itself.
Authorship and Contributorship
In order to avoid disputes and other problems with regard to authorship issues, it is wise to address the issue of authorship when the research is in its planning stages. You should also continue to discuss this issue as the project evolves, being sure to keep a written record of your decisions with regard to authorship. Guidelines on Authorship and Contributorship can be found at the International Committee of Medical Journal Editors site. Additional details, as well as tips on solving authorship problems, can be found here
Mandatory reports in clinical studies
When a study is completed, there are several parties who need to be informed. These include any other departments involved, the department in which the study was carried out, the research staff, the laboratory and, possibly, the pharmacy.
In addition, the Medical Ethics Review Board (CCMO) must be notified by letter, within a period of eight weeks following the visit of the last test subject, that the study has ended. In the event of the early termination of the study, this mandatory period is 15 days. For further details, please visit this page.